Antiproteinuric Effect of an Angiotensin II Receptor Antagonist in Membranous Nephropathy

Publisher： Karger

E-ISSN： 2235-3186|88|2|183-184

ISSN： 1660-8151

Source： Nephron, Vol.88, Iss.2, 2001-05, pp. : 183-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Combination ACE Inhibitor and Angiotensin II Receptor Antagonist Therapy in Diabetic Nephropathy

By  

American Journal of Nephrology, Vol. 19, Iss. 1, 1999-03 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Beneficial Effect of Combination Therapy with an Angiotensin II Receptor Antagonist and Angiotensin-Converting Enzyme Inhibitor on Overt Proteinuria in a Patient with Type 1 Diabetic Nephropathy

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 529-530

Karger

Access to resources Recommend Favorite

Effects of Angiotensin-Converting Enzyme Inhibitor, Angiotensin II Receptor Antagonist and Calcium Antagonist on Urinary Podocytes in Patients with IgA Nephropathy

By  

American Journal of Nephrology, Vol. 20, Iss. 5, 2000-11 ,pp. : 373-379

Karger

Access to resources Recommend Favorite

Comparison between the Angiotensin II Receptor Antagonist Candesartan Cilexetil and the Angiotensin-Converting Enzyme Inhibitor Trandolapril in Microalbuminuria of Patients with Early Diabetic Nephropathy

By  

Nephron, Vol. 86, Iss. 2, 2000-09 ,pp. : 247-247

Karger

Access to resources Recommend Favorite

Effect of Valsartan, an Angiotensin II AT1 Receptor Blocker, on the Glomerular Fibrosis of IgA Nephropathy in ddY Mice

By  

Nephron, Vol. 86, Iss. 3, 2000-11 ,pp. : 374-375

Karger

Access to resources Recommend Favorite